In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Calibra Medical closes $35mm Series B

Executive Summary

Calibra Medical (formerly Seattle Medical Technologies) brought in $35mm via its Series B financing led by first-time backer Canaan Partners. Other new investors Intersouth Partners and Skyline Ventures were joined by returning shareholders Frazier Healthcare Ventures and Three Arch Partners. The company will use the money for the anticipated 2009 launch of its easy-to-use insulin delivery device. Calibra has raised about $46mm since its formation in 2004. A member of Canaan and Skyline will join the board, with a representative from Skyline serving as a board observer.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies